Prior use of therapeutic anticoagulation does not protect
against COVID-19 related clinical outcomes in hospitalized patients: a
propensity score-matched cohort study
J.P. Spiegelenberg1, 2, M.M.H.J. van
Gelder3,4, M.L. Maas5, M.M.C.
Hovens6, A. Esselink7, A.S.M.
Dofferhoff7, R. Janssen8, J. van de
Maat1,2, N. Janssen1,2, M.
Blaauw5, R.J. Hassing6 , M. van
Apeldoorn9, A. Kerckhoffs9, K.
Veerman10, J. Hoogerwerf1,2, C.
Kramers11,12, J. Leentjens1, 2
1 Department of
Internal Medicine, Radboud university medical center, 6500HB Nijmegen,
the Netherlands
2 Radboud Center for Infectious Diseases, Radboud
university medical center, 6500HB Nijmegen, The Netherlands
3 Department for Health Evidence, Radboud Institute
for Health Sciences, Radboud university medical center, 6500HB Nijmegen,
the Netherlands
4 Radboud REshape Innovation Center, Radboud
university medical center, 6500HB Nijmegen, the Netherlands
5 Department of Internal Medicine, Bernhoven, 5406PT
Uden, the Netherlands
6 Department of Internal Medicine, Rijnstate Hospital,
6815AD Arnhem, the Netherlands
7 Department of Internal Medicine, Canisius-Wilhelmina
Hospital, 6500GS Nijmegen, The Netherlands
8 Department of Pulmonary Medicine,
Canisius-Wilhelmina Hospital, 6500GS Nijmegen, The Netherlands
9 Department of Internal Medicin and Geriatricts,
Jeroen Bosch Hospital, 5223 GZ, ’s-Hertogenbosch, the Netherlands
10 St. Maartenskliniek Department of Internal
Medicine, Hengstdal 3 6574 NA Ubbergen, The Netherlands
11 Department of Pharmacology-Toxicology, Radboud
university medical center, 6500HB Nijmegen, the Netherlands
12 Department of Pharmacy, Canisius Willhelmina
Hospital, 6500GS Nijmegen, the Netherlands